Price (delayed)
$277.35
Market cap
$10.68B
P/E Ratio
770.42
Dividend/share
N/A
EPS
$0.36
Enterprise value
$10.58B
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses
There are no recent dividends present for PEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.